FindTrial
Sign In

A random-allocation graded dose-response study of intrathecal bupivacaine, levobupivacaine and ropivacaine for labor analgesia in nulliparous women

A random-allocation graded dose-response study of intrathecal bupivacaine, levobupivacaine and ropivacaine for labor analgesia in nulliparous women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000773
Enrollment
Unknown
Registered
2009-12-22
Start date
2009-12-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labour

Interventions

Three groups:Labouring patients randomized to an intrathecal dose ranging from 0.625 to 6.25 mg of either bupivacaine, levobupivacaine or ropivacaine. Response measured as pain scores for 15 min

Sponsors

Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 51 Years

Inclusion criteria

Inclusion criteria: Healthy term singleton pregnancy in painful first stage of labour

Exclusion criteria

Exclusion criteria: Maternal or fetal disease

Design outcomes

Primary

MeasureTime frame
Reduction in pain score in first 15 min after adminstration;—

Countries

China

Contacts

Public ContactProf Warwick D. Ngan Kee
warwick@cuhk.edu.hk+852 26322735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026